Trademark Overview
On Thursday, April 4, 2024, a trademark application was filed for YIMMUGO with the United States Patent and Trademark Office. The USPTO has given the YIMMUGO trademark a serial number of 98483710. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, October 17, 2024. This trademark is owned by Biotest AG. The YIMMUGO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical products, namely, blood products, in the nature of proteins and protein preparations made from human blood, in particular immunoglobulins and immunoglobulin preparations; Pharmaceutical products for preventing and treating immunological, neurological and hematological disorders; Pharmaceutical products for preventing and treating infectious diseases; Pharmaceutical products for preventing and treating autoimmune diseases; Immunomodulatory, anti-inflammatory, anti-allergic, hyposensitizing, detoxifying and toxine-neutralizing medicines